2 results
Approved WMOCompleted
Primary Objective:• To assess and compare efficacy of sacituzumab govitecan to TPC as measured by progression free survival (PFS) as determined by blinded independent central review (BICR) using Response Evaluation Criteria in Solid Tumors Version 1…
Approved WMORecruiting
To evaluate the immediate impact of TAVI or TMVr on a battery of coronary (non-) hyperemic physiology tests in patient with severe aortic valve stenosis or functional/degenerative mitral regurgitation and at least intermediate coronary artery…